Generation of Mouse Monoclonal Antibody against (-)-Epigallocatechin Gallate

  • Kuzuhara Takashi
    Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Tokushima Bunri University
  • Kise Daisuke
    Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Tokushima Bunri University
  • Shirakawa Yayoi
    Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Tokushima Bunri University
  • Sasada Kinuko
    Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Tokushima Bunri University
  • Suganuma Masami
    Research Institute for Clinical Oncology, Saitama Cancer Center
  • Fujiki Hirota
    Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Tokushima Bunri University

Search this article

Abstract

Green tea is an acknowledged cancer preventive in Japan, and the main constituent of green tea catechins is (−)-epigallocatechin gallate (EGCG). To investigate the bioavailability of EGCG in humans, we generated a monoclonal antibody against EGCG in BALB/c mice by immunizing thyroglobulin-conjugated EGCG. Out of 32 hybridoma cell lines, three hybridomas were selected by enzyme-linked immunosorbent assay (ELISA), and then determined by surface plasmon resonance assay: One hybridoma TG38 produced a specific monoclonal antibody against EGCG. The primary structure of TG38 light chain was then deduced from DNA sequence of the light chain gene. The NCBI-BLAST search showed the uniqueness of TG38 monoclonal antibody, and three amino acid residues specific for TG38 were aligned on two loops and one β-sheet of the tertiary structure of the antibody. The TG38 antibody is the first monoclonal antibody against EGCG and catechins, since it bound to four green tea catechins with a galloyl group.

Journal

Citations (2)*help

See more

References(36)*help

See more

Details 詳細情報について

Report a problem

Back to top